Maybe a letdown - or at least a left turn - was inevitable. A week after Elim Chan made her high-impact debut as music director designate of the San Francisco Symphony, Chinese New Zealand guest ...

Add Yahoo as a preferred source to see more of our stories on Google. Tianyi Lu conducting the San Francisco Symphony on Friday, June 12, 2026. (Brandon Patoc/San Francisco Symphony) Maybe a letdown - ...

Researchers are at a loss for why people across cultures and ages, regardless of their dominant hand, have a natural bias toward wandering in a counterclockwise direction. By Rachel Nuwer Iñaki ...

Outspoken activist short seller Andrew Left was convicted on securities fraud charges over manipulating stock prices — a surprise verdict that sent shock waves through Wall Street. A jury in Los ...

A U.S. jury found prominent investor Andrew Left guilty of securities fraud on Monday, the Justice Department said, in a blow to a divisive cohort of short sellers who have for years ‌goaded public ...

Famed short seller Andrew Left faces the possibility of decades behind bars after being found guilty of using disingenuous social media posts to manipulate stocks, in a landmark case that threatens to ...

LOS ANGELES—Andrew Left earned fame and fortune by researching companies, accusing them of fraud and betting their stock price would fall. On Monday, a federal jury convicted him of securities fraud, ...

NBC Select independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more. Harry Rabinowitz Tech Reporter Cory Fernandez Commerce ...

A recent study suggests that left-handed people have an advantage in competitive contexts, while righties tend to cooperate better. Thank “evolutionarily stable strategy” for the mix. A study ...

Left-handers are more competitive than right-handers, according to a new study published in the journal Scientific Reports. The findings may help explain why left-handedness has persisted throughout ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...